ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS – Get Free Report) saw a large decline in short interest in the month of October. As of October 15th, there was short interest totalling 6,800 shares, a decline of 20.0% from the September 30th total of 8,500 shares. Based on an average daily volume of 13,700 shares, the days-to-cover ratio is presently 0.5 days.
Institutional Inflows and Outflows
An institutional investor recently raised its position in ProShares UltraShort Nasdaq Biotechnology stock. IMC Chicago LLC boosted its position in ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS – Free Report) by 68.1% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 25,210 shares of the company’s stock after acquiring an additional 10,209 shares during the period. IMC Chicago LLC owned 11.46% of ProShares UltraShort Nasdaq Biotechnology worth $443,000 as of its most recent SEC filing.
ProShares UltraShort Nasdaq Biotechnology Stock Down 1.9 %
Shares of NASDAQ:BIS traded down $0.30 during midday trading on Tuesday, reaching $15.24. The company’s stock had a trading volume of 13,224 shares, compared to its average volume of 14,053. The firm has a 50 day moving average price of $14.99 and a two-hundred day moving average price of $16.35. ProShares UltraShort Nasdaq Biotechnology has a fifty-two week low of $14.05 and a fifty-two week high of $26.51.
ProShares UltraShort Nasdaq Biotechnology Cuts Dividend
ProShares UltraShort Nasdaq Biotechnology Company Profile
ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period.
Featured Stories
- Five stocks we like better than ProShares UltraShort Nasdaq Biotechnology
- P/E Ratio Calculation: How to Assess Stocks
- Is McDonald’s Stock a Smart Buy After Sell-Off and Earnings?
- 5 Top Rated Dividend Stocks to Consider
- QuantumScape: Solid State EV Batteries Nearing Commercialization
- What Are Trending Stocks? Trending Stocks Explained
- MicroStrategy: Is This Bitcoin-Powered Stock a Buy or a Gamble?
Receive News & Ratings for ProShares UltraShort Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares UltraShort Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.